Condition: Metabolic Disorder · End Stage Renal Disease · Rare Diseases · Sponsor: University Hospital, Lille
The investigators propose to set up a prospective randomized controlled trial to control the security and assess the efficacy of adjuvant treatment by rheopheresis in necrotizing-ulcered calciphylaxis in the hemodialysis population.
This description comes directly from the study's public registry record.
Arnaud Lionet, MD · 0320445000 · arnaud.lionet@chru-lille.fr
Always discuss trial participation with your own doctor first.
| CHU d'Angers | Angers, France | Not Yet Recruiting |
| CHU d'Arras | Arras, France | Recruiting |
| CHU d'Auxerre | Auxerre, France | Not Yet Recruiting |
| CHU de Besançon, Hôpital Jean Minjoz | Besançon, France | Recruiting |
| CH de Béthune | Béthune, France | Recruiting |
| CH de Boulogne sur Mer | Boulogne-sur-Mer, France | Recruiting |
| CHU de Bordeaux | Bourdeaux, France | Not Yet Recruiting |
| CHRU de Brest | Brest, France | Not Yet Recruiting |
| CHU de Caen | Caen, France | Not Yet Recruiting |
| Hôpital Nord Michallon, CHU de Grenoble | Grenoble, France | Recruiting |
| Centre ECHO Laval | Laval, France | Recruiting |
| Centre ECHO Le Mans | Le Mans, France | Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04654000